Cargando…
CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis
BACKGROUND: Increasing evidence suggests that the metabolism of lipids plays a crucial role in the progression of gastric cancer. However, the expression of lipid metabolism-related genes (LMGs) still does not serve as a prognostic biomarker in gastric cancer. METHODS: We obtained transcriptome data...
Autores principales: | Zhou, Xinyi, Meng, Fanyu, Xiao, Linmei, Shen, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544546/ https://www.ncbi.nlm.nih.gov/pubmed/37784135 http://dx.doi.org/10.1186/s12920-023-01664-y |
Ejemplares similares
-
Lipid Metabolic-Related Signature CYP19A1 is a Potential Biomarker for Prognosis and Immune Cell Infiltration in Gastric Cancer
por: Wang, Nan, et al.
Publicado: (2022) -
A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma
por: Zhang, Kai, et al.
Publicado: (2022) -
NF-κB-Related Metabolic Gene Signature Predicts the Prognosis and Immunotherapy Response in Gastric Cancer
por: Chen, Qiuxiang, et al.
Publicado: (2022) -
Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer
por: Sun, YuQin, et al.
Publicado: (2023) -
A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer
por: Liu, Shi-jin, et al.
Publicado: (2021)